Arama Sonuçları - Yihui Weng
- Gösterilen 1 - 2 sonuçlar arası kayıtlar. 2
-
1
MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1 Yazar: Zhebin Dong, Hengmiao Wu, Yi-cheng He, Zhongting Huang, Yihui Weng, Hong Li, Chao Liang, Weiming Yu, Wei Chen
Baskı/Yayın Bilgisi 2022Artigo -
2
Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review Yazar: Stefania Boccia, Rayjean J. Hung, Walter Ricciardi, Francesco Gianfagna, M. Ebert, Jing‐Yuan Fang, Changchun Gao, Tobias Götze, Francesco Graziano, Marina Lacasaña‐Navarro, Dongxin Lin, Lizbeth López‐Carrillo, You‐Lin Qiao, Hongyu Shen, Rachael Z. Stolzenberg‐Solomon, Toshiro Takezaki, Yihui Weng, F. F. Zhang, Cornelia M. van Duijn, Paolo Boffetta, Emanuela Taioli
Baskı/Yayın Bilgisi 2007Revisão
Arama Araçları:
İlgili Konular
Gene
Internal medicine
Medicine
AKT1
AKT2
Apoptosis
Biochemistry
Biology
Cancer
Cancer research
Case-control study
Chemistry
Confidence interval
Downregulation and upregulation
Gastroenterology
Genetics
Genotype
Hepatocellular carcinoma
Meta-analysis
Methylenetetrahydrofolate reductase
Odds ratio
Oncology
PI3K/AKT/mTOR pathway
Pooled analysis
Publication bias
Sorafenib
microRNA